Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International ConsortiumJack F. Shern, Javed Khan, Joanna Selfe et al.|Journal of Clinical Oncology|2021Cited by 221
Dinutuximab Beta Added to Temozolomide-Based Chemotherapy for Children With Relapsed and Refractory Neuroblastoma: Results of the ITCC-SIOPEN BEACON Immuno Phase II TrialJuliet C. Gray, Lucas Moreno, Marion Gambart et al.|Journal of Clinical Oncology|2025Cited by 8